Improving brachytherapy for cervical cancer using MRI technology
Changing brachytherapy with MRI remnant-tumor segmentation and active-catheter placement
['FUNDING_R01'] · JOHNS HOPKINS UNIVERSITY · NIH-10805453
This study is looking at a new way to help people with cervical cancer by using MRI to better find leftover tumors after radiation treatment, so doctors can place tiny tubes more accurately and safely, leading to fewer side effects and better results for patients.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10805453 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the treatment of cervical cancer by using MRI to accurately identify residual tumors after initial radiation therapy. The approach involves placing catheters into the tumor with the guidance of MRI, which helps avoid damage to surrounding healthy tissues. By improving the precision of catheter placement, the study aims to reduce complications and improve treatment outcomes for patients. The research seeks to streamline the process, making it less labor-intensive and more effective.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with locally advanced cervical cancer who are undergoing treatment involving external beam radiation followed by brachytherapy.
Not a fit: Patients with early-stage cervical cancer or those who are not candidates for brachytherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer treatment options for women with cervical cancer.
How similar studies have performed: Previous research has shown that MRI-guided brachytherapy can improve treatment outcomes, indicating that this approach has potential for success.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VISWANATHAN, AKILA — JOHNS HOPKINS UNIVERSITY
- Study coordinator: VISWANATHAN, AKILA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer